Limitations in the Use of Serum Epidermal Growth Factor Receptor Mutations as Prognostic Markers for Non-Small-Cell Lung Cancer

Publisher： Karger

E-ISSN： 1423-0151|24|5|486-490

ISSN： 1011-7571

Source： Medical Principles and Practice, Vol.24, Iss.5, 2015-06, pp. : 486-490

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Post‐diagnosis weight loss as a prognostic factor in non‐small cell lung cancer

By  

Journal Of Cachexia Sarcopenia And Muscle, Vol. 9, Iss. 1, 2018-02 ,pp. : 86-92

John Wiley & Sons Inc

Access to resources Recommend Favorite

The impact of cardiovascular comorbidities on the outcome of surgery for non-small-cell lung cancer

By Takenaka Tomoyoshi   Katsura Masakazu   Shikada Yasunori   Tsukamoto Syuichi   Takeo Sadanori  

Interactive CardioVascular and Thoracic Surgery, Vol. 16, Iss. 3, 2013-03 ,pp. : 270-274

Oxford University Press

Access to resources Recommend Favorite

Combined Modality Treatment of Non-Small-Cell Lung Cancer

By Westeel V.   Depierre A.  

American Journal of Respiratory Medicine, Vol. 2, Iss. 6, 2003-01 ,pp. : 477-490

Adis International

Access to resources Recommend Favorite

Surgical treatment of non-small-cell lung cancer in octogenarians

By Guerra Miguel   Neves Paulo   Miranda Jos  

Interactive CardioVascular and Thoracic Surgery, Vol. 16, Iss. 5, 2013-05 ,pp. : 673-680

Oxford University Press

Access to resources Recommend Favorite

Comparative Proteomic Analysis of Non-small-cell Lung Cancer and Normal Controls Using Serum Label-Free Quantitative Shotgun Technology

By Pan Jun  

Lung, Vol. 186, Iss. 4, 2008-08 ,pp. : 255-261

Springer Publishing Company

Access to resources Recommend Favorite